Centiva Capital, LP - VANECK VECTORS ETF TR ownership

VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 715 filers reported holding VANECK VECTORS ETF TR in Q4 2020. The put-call ratio across all filers is 1.18 and the average weighting 0.6%.

Quarter-by-quarter ownership
Centiva Capital, LP ownership history of VANECK VECTORS ETF TR
ValueSharesWeighting
Q3 2023$7,951,905
+691.5%
295,500
+785.7%
0.18%
+660.9%
Q2 2023$1,004,620
-16.9%
33,365
-20.9%
0.02%
+35.3%
Q4 2022$1,209,280
+150.9%
42,194
+111.0%
0.02%
+88.9%
Q3 2022$482,000
-61.8%
20,000
-56.6%
0.01%
-70.0%
Q2 2022$1,261,000
-70.1%
46,070
-58.1%
0.03%
-63.0%
Q1 2022$4,220,000
-69.5%
110,000
-74.6%
0.08%
-71.7%
Q4 2021$13,850,000
+1007.1%
432,434
+917.5%
0.29%
+266.7%
Q3 2021$1,251,000
-91.7%
42,500
-90.4%
0.08%
-78.2%
Q2 2021$15,122,000
-43.6%
445,000
-46.1%
0.36%
-65.1%
Q1 2021$26,812,000
-16.8%
825,000
-7.8%
1.02%
-18.7%
Q4 2020$32,238,000
+458.6%
894,997
+258.0%
1.26%
+386.1%
Q1 2020$5,771,000
-53.1%
250,000
-45.7%
0.26%
-65.6%
Q3 2019$12,299,000
-39.9%
460,478
-42.4%
0.75%
-38.3%
Q2 2019$20,448,000
-37.7%
800,000
-45.3%
1.22%
-44.7%
Q1 2019$32,819,000
+22.3%
1,463,800
+15.1%
2.21%
+4.1%
Q4 2018$26,826,000
+9.3%
1,271,900
-4.0%
2.12%0.0%
Q3 2018$24,536,0001,324,8612.12%
Other shareholders
VANECK VECTORS ETF TR shareholders Q4 2020
NameSharesValueWeighting ↓
Memorial Sloan Kettering Cancer Center 738,500$19,873,03580.92%
New Harbor Financial Group, LLC 1,680,752$45,229,03314.96%
TORQ CAPITAL MANAGEMENT (HK) Ltd 139,000$3,740,4909.95%
Vanderbilt University 1,360,540$36,612,1319.45%
Eschler Asset Management LLP 300,000$8,073,0009.42%
New Harbor Financial Group, LLC 1,027,300$27,644,6439.15%
Guild Investment Management, Inc. 139,333$3,749,4546.28%
Monaco Asset Management SAM 750,000$20,182,5005.98%
STRATEGIC INVESTMENT MANAGEMENT, LLC 132,460$3,867,8324.74%
PCG Wealth Advisors, LLC 264,614$7,120,7824.67%
View complete list of VANECK VECTORS ETF TR shareholders